Ajax-Loading

Sanofi SA - Stock Based Compensation

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Millions.

The item "Stock-Based-Compensation" stands at 173.00 Million Euros for the trailing twelve months (TTM) period ending 03/31/2025, the lowest value since 12/31/2016.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -60.95 percent compared to the value the year prior.
The 1 year change in percent is -60.95.
The 3 year change in percent is -54.23.
The 5 year change in percent is -54.83.
The 10 year change in percent is 103.53.

The Serie's long term average value is 340.78 Million Euros. It's latest available value, on 03/31/2025, is 49.23 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 03/31/2025, is +103.53%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 03/31/2025, is -62.06%.

Stock Based Compensation for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Stock Based Compensation905,699,262,464.00
LogoJohnson & Johnson - Stock Based Compensation486,508,953,600.00
LogoAbbVie Inc - Stock Based Compensation399,570,305,024.00
LogoRoche Holding AG - Stock Based Compensation317,433,206,677.55
LogoAstraZeneca PLC - Stock Based Compensation280,205,508,085.11